Champions Oncology (CSBR) Cash from Financing Activities (2010 - 2026)
Champions Oncology's (CSBR) quarterly Cash from Financing Activities came in at $33000.0 in Q3 2026, up 335.71% year-over-year from $7573.8 in Q3 2025, and up 273.68% on a QoQ basis from -$19000.0 in Q2 2026.
Powered by 
Analysis
Champions Oncology (CSBR) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Champions Oncology (CSBR) has 17 years of Cash from Financing Activities data on file, last reported at $33000.0 in Q3 2026.
- On a quarterly basis, Cash from Financing Activities rose 335.71% year-over-year to $33000.0 in Q3 2026; TTM through Jul 2026 was $146000.0, a 24.35% decrease from a year earlier, with the FY2026 full-year figure at $99000.0, down 41.76% from the prior year.
- Cash from Financing Activities for Q3 2026 stood at $33000.0, up from -$19000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $239000.0 in Q4 2024 and bottomed at -$590000.0 in Q3 2023.
- Historically, Cash from Financing Activities has averaged -$8125.0 across 5 years, with a median of -$16500.0 in 2025.
- The widest annual swing landed in 2023, when Cash from Financing Activities sank 568.75%; it then soared 335.71% in 2026.
- Year by year, Cash from Financing Activities stood at $86000.0 in 2022, then soared by 55.81% to $134000.0 in 2023, then surged by 78.36% to $239000.0 in 2024, then declined by 29.71% to $168000.0 in 2025, then plunged by 80.36% to $33000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were $33000.0 in Q3 2026, -$19000.0 in Q2 2026, and -$36000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -214.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -288.34 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -8.12 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -164.66 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 16.49 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 33,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 248,151.59 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -118,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 33,000.00 |
| Apr 30, 2026 | -19,000.00 |
| Jan 31, 2026 | -36,000.00 |
| Oct 31, 2025 | 168,000.00 |
| Jul 31, 2025 | -14,000.00 |
| Apr 30, 2025 | -32,000.00 |
| Oct 31, 2024 | 239,000.00 |
| Jul 31, 2024 | -37,000.00 |
| Apr 30, 2024 | -37,000.00 |
| Jan 31, 2024 | -34,000.00 |
| Oct 31, 2023 | 134,000.00 |
| Jul 31, 2023 | -590,000.00 |
| Apr 30, 2023 | -75,000.00 |
| Oct 31, 2022 | 86,000.00 |
| Apr 30, 2022 | 16,000.00 |
| Jan 31, 2022 | 68,000.00 |
| Oct 31, 2021 | 121,000.00 |
| Jul 31, 2021 | 2,000.00 |
| Apr 30, 2021 | 72,000.00 |
| Jan 31, 2021 | -56,000.00 |